Uses of Rotorlip 10

Drug Rotorlip 10 is indicated as an adjunct to diet therapy in cases of patients with primary hypercholesterolemia, hypertriglyceridemia, and to slow the progression of atherosclerosis .... So the drug Rotorlip 10mg is what medicine? What is the correct way to drink? What points need to be noted and taken care of when using?

Rotorlip drug 10mg is used as an adjunct to the treatment of primary hypercholesterolemia, primary dyslipidemia, hypertriglyceridemia, and to slow the progression of coronary atherosclerosis. Primary prevention of cardiovascular diseases such as: reducing the risk of stroke, myocardial infarction, coronary revascularization procedures in patients at high risk for cardiovascular disease without clinical manifestations. obvious coronary artery disease.
Rotorlip medicine 10mg with the main ingredient is Rosuvastatin Calci is prepared in the form of film-coated tablets, packed in blisters of 10 tablets, each box of 3 blisters.

Patients need to have a reasonable diet before being treated with Rotorlip and need to maintain these diets throughout the course of treatment.
Initial dose: Rotorlip 5 to 10 mg once a day, at any time of the day, with meals or on an empty stomach. The dose can be adjusted every 4 weeks if necessary. The maximum dose is 40 mg once a day, close monitoring is required for those taking a dose of 40 mg.
Children (10 - 17 years old): 5 - 20 mg per day, maximum 20 mg per day.
Patients using atazanavir, atazanavir plus ritonavir, lopinavir plus ritonavir: Maximum 10 mg/day.
Patients with severe renal impairment (ClCr < 30 ml/min), not on hemodialysis: Initial dose of 5 mg/day, maximum not to exceed 10 mg/day.
Note: The above dosage is for reference only. The specific dose depends on the condition and the progression of the disease. To get the right dose, you need to consult your doctor or medical professional
Handling missed dose: If the patient forgets a dose, take the dose as soon as you remember it. However, if the interval between the next dose is too short, skip the missed dose and resume the dosing schedule. Do not take a double dose to make up for a missed dose.
Treatment of overdose: There is no specific treatment for overdose with Rosuvastatin. In case of overdose, initiate symptomatic treatment and necessary supportive measures. Hemodialysis does not significantly increase the clearance of Rosuvastatin.

Rotorlip is contraindicated in the following cases:
Hypersensitivity to any component of the drug, active liver disease or unexplained persistent elevations in serum transaminases, severe renal impairment, myopathy, patients with are taking cyclosporine. Drug interactions can affect how drugs work or cause side effects. Tell your doctor or pharmacist a list of all the medications and supplements you are taking. Do not take or increase or decrease the dose of this medicine without consulting your doctor. There is an increased risk of muscle damage when rosuvastatin is used concomitantly with the following drugs: Gemfibrozil, other fibrate-lowering agents, high-dose niacin (>1g/day), colchicine, cyclosporin, itraconazole, ketoconazole. Concomitant use of lipid-lowering drugs of the statin group with drugs to treat HIV and hepatitis C virus (HCV) may increase the risk of muscle damage, most seriously rhabdomyolysis, kidney failure leading to kidney failure and can be fatal. Rosuvastatin may potentiate the effects of warfarin and increase the bioavailability of oral contraceptives when taken together. Antacids (containing aluminum hydroxide and magnesium hydroxide) and erythromycin can markedly reduce the bioavailability of rosuvastatin when co-administered. Therefore, the time to use these drugs with Rotorlip must be separated, at least 2 hours. The drug is contraindicated for pregnant and lactating women.

Before starting treatment with Rotorlip 10mg of rosuvastatin, patients need to combine blood cholesterol control with a number of measures such as diet, weight loss, exercise, treatment of diseases that may be the cause of the disease. increased lipids in the blood. The patient should conduct lipid measurement periodically and adjust the drug dose according to the patient's response to the drug. Use LDL cholesterol levels to initiate treatment and assess response to treatment.

Adverse reactions reported with Rosuvastatin are generally mild and transient. In controlled clinical studies, less than 4% of Rosuvastatin-treated patients withdrew due to an adverse event. The frequency of adverse reactions is as follows:
Nervous system disorders: headache, dizziness. Digestive system disorders: constipation, nausea, abdominal pain. Musculoskeletal, connective tissue and bone disorders: muscle pain To ensure the best safety when there are health abnormalities, patients should contact their doctor for advice to have appropriate indications. best.
In summary, the drug Rotorlip 10 is indicated as an adjunct to diet therapy in patients with primary hypercholesterolemia, hypertriglyceridemia, and to slow the progression of atherosclerosis... Therefore, The drug should be used only when prescribed by a medical professional.